Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Christophe Degois

<< Previous

Bullboard Posts

Next >>

Comment by Peladawnon Aug 01, 2024 11:44am

71 Views

Post# 36158379

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Christophe Degois

According to the true polls, you know, the ones that aren't censored by the corrupt leftwing social media giants, the Trump Campaign is leading virtually everywhere and in all demographics...but I'll repost your latest diatribes here, after November 5 to show how ridiculous you look.

<< Previous

Bullboard Posts

Next >>

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal